Benitec Biopharma Inc BNTC

schabacker_idol

To me this looks like a good opportunity. Price is at market structure right after offering on the same level.

AlenCiken

Benitec Shares Skyrocket as Morgan Stanley Takes Stake $BNTC shares blasted higher Tuesday after disclosing in a regulatory filing that Morgan Stanley has a 5.2% stake in the genetic drug company. The stake amounts to 249,174 shares, or about $1.51 million. Benitec‘s “proprietary platform, called DNA-directed RNA interference, or ddRNAi, combines RNA...

multiassetxplorations

Greetings Humbled, we would like to thanks for your support who has already liked, commented and followed us. Your support, strengthens us, to help in analyzing the market. If you have any questions, feel free to send us message (inbox). Pra Trading : - Please care for Money Management - Have a good psychology - Do not be hurry to open position and do not do...

CryptoFundManager

Morgan Stanley disclosed in an SEC filing that it had increased its stake in the company by around 5.2%! Don`t worry, it has still upside potential, despite the 130% increase in the Pre-Market. Market Cap of only 15.37M This is a 5X stock, Not trading advice as you know! :) This was a private call from my trading group and one of my top picks for March. You...

HorizontalPriceLevelsTrading

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed...

BuySellMarketMaker

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy...

CRYPTOBMF

I’m strongly monitoring this reversal and i expect a great return on my investment. An alternative could be $TLGT!

freddiegbruh

Next stop: $4.51

ParisFrance

sell

Rotuma

BENITEC BIOPHARMA share prices pulled back from 11.60 highs in the 30 minutes chart and attempted to hold at $8.00 support price level from the time of writing. It will need to remain above the $8.00 mark to head back to $9.50 target. Support awaits at around $7.25 and $6.60 if it fails at $8.00

pegging44

b

AntonioNaVi

Long>3.23 Stop - 2.99 Target - 3.99

EngageTheTrade

No specific plan here, just watch this pennant formation. These have been going off often (see AUPH, OREX) recently.

redaidriss

A High % Loser , BNTC with a beautiful double top , a Hight probability set up to continue to colapse first Target , our 2.00 support level .

TalyC88

Since 26-Jan-2017 i will publish here ideas of my new strategy trading: "Stock to buy before gap up!" Please do not use my ideas! its just under-review! If you want to make a pledge at this project and reward a doc with the strategy, please contact me.